★ WIDE MOAT STOCKS & COMPETITIVE ADVANTAGES ★
VOL. XCIV, NO. 247
Stock Profile
HOYA Corporation (7741) Moat Analysis
HOYA Corporation
7741 · Tokyo Stock Exchange
Partial score covering 79% of segment weight.
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Request update
Spot something outdated? Send a quick note and source so we can refresh this profile.
Overview
HOYA is a Japanese med-tech and high-tech materials company spanning Life Care and Information Technology. Revenue for the year ended March 2026 was JPY 947.7bn, led by health-care products (~48%) and electronics-related products (~31%); the next results are scheduled for July 31, 2026. The clearest defensible advantages are Eyecity's nationwide Japanese retail network (381 stores at July 1, 2026) and qualification-driven switching costs in advanced semiconductor mask blanks, where HOYA works with customers on angstrom-generation development and qualification. HOYA also reports leading positions in eyeglass lenses, endoscopes, HDD glass substrates, and specialty optics, but market position, regulatory compliance, and manufacturing complexity alone do not establish separate moat mechanisms. The March 2026 quarter reached record quarterly revenue and operating profit, with mask blanks and HDD substrates driving full-year IT growth. Key risks include EUV multi-sourcing, healthcare tender and procurement pressure, and semiconductor/display cyclicality; the voice-synthesis business was transferred on October 27, 2025.
Primary segment
Eye Health Domain (healthcare-related products)
Market structure
Oligopoly
Market share
—
HHI: —
Coverage
5 segments · 7 tags
Updated 2026-07-12
Segments
Eye Health Domain (healthcare-related products)
Ophthalmic products (eyeglass lenses, contact lens retail, intraocular lenses)
Revenue
47.6%
Structure
Oligopoly
Pricing
moderate
Share
—
Peers
Med-Tech Domain (medical-related products)
Medical devices for endoscopy and related med-tech (endoscopes, surgical instruments, disinfection systems, implants, chromatography media)
Revenue
14.8%
Structure
Oligopoly
Pricing
moderate
Share
—
Peers
Electronics-related products (semiconductor/display photomask materials, HDD substrates)
Photomask ecosystem materials (mask blanks and photomasks) for semiconductors and displays; HDD substrate materials
Revenue
31.2%
Structure
Oligopoly
Pricing
strong
Share
—
Peers
Imaging-related products (optical lenses and optical materials)
Optical lenses and materials for cameras and automotive imaging
Revenue
6.2%
Structure
Competitive
Pricing
moderate
Share
—
Peers
Other (speech synthesis software)
Speech synthesis software
Revenue
0.2%
Structure
Competitive
Pricing
weak
Share
—
Peers
Moat Claims
Eye Health Domain (healthcare-related products)
Ophthalmic products (eyeglass lenses, contact lens retail, intraocular lenses)
Revenue share calculated from FY ended 2026-03-31 quarterly report full-year product breakdown: Health care related products revenue from external customers (JPY 450,760m) / total (JPY 947,749m).
Physical Network Density
Supply
Physical Network Density
Strength
Durability
Confidence
Evidence
Eyecity combines Japan-wide physical convenience with a leading specialist-channel position: its operating subsidiary reported 381 domestic stores at July 1, 2026, while HOYA reported improving retention from private-label products and subscriptions.
Physical Network Density moat: definition, examples, and stocks
Erosion risks
- Shift to online retailers and subscription models
- Rising store labor and rent costs
- Regulatory changes affecting contact lens dispensing channels
Leading indicators
- Same-store sales and store count in the contact-lens retail chain
- Online share of contact-lens purchases in Japan
- Customer acquisition costs for new stores
Counterarguments
- Online-first competitors can undercut pricing and reduce foot traffic
- Physical retail density may be less valuable as telemedicine expands
Med-Tech Domain (medical-related products)
Medical devices for endoscopy and related med-tech (endoscopes, surgical instruments, disinfection systems, implants, chromatography media)
Revenue share calculated from FY ended 2026-03-31 quarterly report full-year product breakdown: Medical related products revenue from external customers (JPY 139,919m) / total (JPY 947,749m).
Insufficient segment-specific evidence to assign a moat claim.
Electronics-related products (semiconductor/display photomask materials, HDD substrates)
Photomask ecosystem materials (mask blanks and photomasks) for semiconductors and displays; HDD substrate materials
Revenue share calculated from FY ended 2026-03-31 quarterly report full-year product breakdown: Electronics related products revenue from external customers (JPY 295,757m) / total (JPY 947,749m).
Design In Qualification
Demand
Design In Qualification
Strength
Durability
Confidence
Evidence
Advanced-node semiconductor mask blanks require close collaboration and customer qualification; once qualified, switching suppliers is slow and risky (yield/defect sensitivity).
Design In Qualification moat: definition, examples, and stocks
Erosion risks
- Customer multi-sourcing policies for EUV mask blanks
- Technology transitions (e.g., new lithography approaches) reducing mask blank value
- Yield/defect excursions causing qualification loss
Leading indicators
- Share of customer qualifications at leading-edge nodes
- EUV/High-NA roadmap milestones and capex cadence
- Customer commentary on multi-sourcing
Counterarguments
- Large customers can force dual-sourcing and negotiate pricing
- Competitors may catch up at new nodes, compressing margins
Imaging-related products (optical lenses and optical materials)
Optical lenses and materials for cameras and automotive imaging
Revenue share calculated from FY ended 2026-03-31 quarterly report full-year product breakdown: Imaging related products revenue from external customers (JPY 58,994m) / total (JPY 947,749m).
Insufficient segment-specific evidence to assign a moat claim.
Other (speech synthesis software)
Speech synthesis software
Revenue share calculated from FY ended 2026-03-31 quarterly report full-year product breakdown: Other revenue from external customers (JPY 2,318m) / total (JPY 947,749m). HOYA transferred the voice synthesis software business on 2025-10-27.
Insufficient segment-specific evidence to assign a moat claim.
Evidence
Eyecity store count: 381 domestic stores (as of July 1, 2026).
The current nationwide footprint directly supports a physical distribution and convenience advantage.
HOYA is the market leader in Japan's specialist contact lens retail channel.
Channel leadership is consistent with network density and scale advantages.
Customer retention continued to improve thanks to private-label products and subscription services.
Current results show that the store network is reinforced by private-label and recurring-purchase programs.
HOYA holds an exceptionally high market share, supported by a proven track record... through close collaboration with customers.
Customer collaboration and high share are consistent with qualification-driven switching costs.
...lead the development and qualification of the angstrom-generation in collaboration with customers.
Explicit reference to joint development/qualification supports a design-in/qualification moat.
Risks & Indicators
Erosion risks
- Shift to online retailers and subscription models
- Rising store labor and rent costs
- Regulatory changes affecting contact lens dispensing channels
- Customer multi-sourcing policies for EUV mask blanks
- Technology transitions (e.g., new lithography approaches) reducing mask blank value
- Yield/defect excursions causing qualification loss
Leading indicators
- Same-store sales and store count in the contact-lens retail chain
- Online share of contact-lens purchases in Japan
- Customer acquisition costs for new stores
- Share of customer qualifications at leading-edge nodes
- EUV/High-NA roadmap milestones and capex cadence
- Customer commentary on multi-sourcing
Research 7741 elsewhere
Keep the research going
More Rankings & Systems
Quality Stocks
High quality stocks ranked by profitability, margins, free cash flow quality, durability, solvency, and accounting...
Stock rankingUndervalued Stocks
Undervalued stocks from the NA & Europe universe, ranked with a multi-measure value system and quality controls.
Stock rankingDividend Stocks
Dividend stocks ranked by payout yield, payout sustainability, dividend growth, quality, balance-sheet safety, risk...
Stock rankingDefensive Stocks
Defensive stocks ranked by low volatility, low beta, intermediate momentum, durable profitability, balance sheet...
Stock rankingMomentum Stocks
Momentum stocks ranked by total return momentum, relative momentum, trend confirmation, and risk-adjusted momentum...
Stock rankingConviction 10
A concentrated 10-stock strategy from the NA & Europe universe, ranked across quality, value, growth, momentum, and...
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.